Leading the Way in Life Science Technologies

GEN Exclusives

More »
GEN Podcasts Back to Item »

NEW WAY OF LOOKING AT PEDIATRIC INFECTIOUS DISEASES

- Interview with Jean-Laurent Casanova, M.D., Ph.D., Professor of Medicine, Head of the Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University and Editor in Chief of a new peer-reviewed journal, Inborn Errors of Immunity



  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »